Soluble α-klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Lee, Eun Young ^a   Kim, Sang Soo ^b   Lee, Ji Sung ^a   Kim, In Joo ^b   Song, Sang Heon ^b   Cha, Seung Kuy ^c   Park, Kyu Sang ^c   Kang, Jeong Suk ^a   Chung, Choon Hee ^c  

^a Soonchunhyang University   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA KLOTHO PROTEIN; CREATININE; GLYCOSIDASE; UNCLASSIFIED DRUG; BETA GLUCURONIDASE; BIOLOGICAL MARKER; KLOTHO PROTEIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; BLOOD; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; PATHOLOGY; RISK FACTOR; URINE;

ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLUCURONIDASE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84905384708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102984     Document Type: Article

References (24)

1. Kuro-o M (2012) Klotho in health and disease. Curr Opin Nephrol Hypertens 21: 362-368.
2. Hu MC, Kuro-o M, Moe OW (2012) Secreted klotho and chronic kidney disease. Adv Exp Med Biol 728: 126-157.
3. Hu MC, Shi M, Zhang J, Quiñones H, Griffith C, et al. (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22: 124-136.
4. Kim HR, Nam BY, Kim DW, Kang MW, Han JH, et al. (2013) Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis 61: 899-909.
5. Akimoto T, Yoshizawa H, Watanabe Y, Numata A, Yamazaki T, et al. (2012) Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease. BMC Nephrol 13:155.
6. Lin Y, Kuro-O M, Sun Z (2013) Genetic deficiency of anti-aging gene Klotho exacerbates early nephropathy in STZ-induced diabetes in male mice. Endocrinology 154: 3855-3863.
7. Asai O, Nakatani K, Tanaka T, Sakan H, Imura A, et al. (2012) Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int 81: 539-547.
8. Zhao Y, Banerjee S, Dey N, LeJeune WS, Sarkar PS, et al. (2011) Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 60: 1907-1916.
9. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, et al. (2006) Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52: 5-18. (Pubitemid 43032461)
10. Cha SK, Ortega B, Kurosu H, Rosenblatt KP, Kuro-O M, et al. (2008) Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci U S A 105: 9805-9810. (Pubitemid 352031381)
11. Van Ark J, Hammes HP, Van Dijk MC, Vervloet MG, Wolffenbuttel BH, et al. (2013) Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy. Cardiovasc Diabetol 12: 116.
12. Kacso IM, Bondor CI, Kacso G (2012) Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. Clin Biochem 45: 1415-1420.
13. Devaraj S, Syed B, Chien A, Jialal I (2012) Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease. Am J Clin Pathol 137: 479-485.
14. Hu MC, Moe OW (2012) Klotho as a potential biomarker and therapy for acute kidney injury. Nat Rev Nephrol 8: 423-429.
15. Hu MC, Kuro-o M, Moe OW (2012) The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant 27: 2650-2657.
16. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, et al. (2005) Suppression of aging in mice by the hormone Klotho. Science 309: 1829-1833. (Pubitemid 41325087)
17. Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR (2007) Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci USA 104: 19796-19801.
18. Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, et al. (2005) The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 21;310: 490-493. (Pubitemid 41507962)
19. Cha SK, Hu MC, Kurosu H, Kuro-o M, Moe O, et al. (2009) Regulation of renal outer medullary potassium channel and renal K(+) excretion by Klotho. Mol Pharmacol 76: 38-46.
20. Adetunji OR, Mani H, Olujohungbe A, Abraham KA, Gill GV (2009) 'Microalbuminuric anaemia' - the relationship between haemoglobin levels and albuminuria in diabetes. Diabetes Res Clin Pract 85: 179-182.
21. Lang F, Lang E, Föller M (2012) Physiology and pathophysiology of eryptosis. Transfus Med Hemother 39: 308-314.
22. Kempe DS, Ackermann TF, Fischer SS, Koka S, Boini KM, et al. (2009) Accelerated suicidal erythrocyte death in Klotho-deficient mice. Pflugers Arch 458: 503-512.
23. Lim SC, Liu JJ, Subramaniam T, Sum CF (2013) Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetes patients. J Renin Angiotensin Aldosterone Syst [Epub ahead of print].
24. Karalliedde J, Maltese G, Hill B, Viberti G, Gnudi L (2013) Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria. Clin J Am Soc Nephrol 8: 1899-1905.